[{"AccountsPayableCurrent_0_Q3_USD":846000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":40000.0,"OtherReceivablesNetCurrent_0_Q3_USD":360000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-74000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":3000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-78000.0,"OtherAssetsNoncurrent_0_Q3_USD":557000.0,"OtherAssetsCurrent_0_Q3_USD":734000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":104000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":867000.0,"OperatingLeasePayments_3_Q3_USD":175000.0,"OperatingLeasePayments_1_Q3_USD":60000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":543000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":408000.0,"OperatingLeaseLiability_0_Q3_USD":951000.0,"OperatingLeaseCost_3_Q3_USD":209000.0,"OperatingLeaseCost_1_Q3_USD":91000.0,"OperatingIncomeLoss_3_Q3_USD":-68994000.0,"OperatingIncomeLoss_1_Q3_USD":-28603000.0,"OperatingExpenses_3_Q3_USD":68994000.0,"OperatingExpenses_1_Q3_USD":28603000.0,"NonoperatingIncomeExpense_3_Q3_USD":-74000.0,"NonoperatingIncomeExpense_1_Q3_USD":3000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"NetIncomeLoss_3_Q3_USD":-69192000.0,"PreferredStockValue_0_Q3_USD":null,"PrepaidInsurance_0_Q3_USD":1517000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":276000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":35732000.0,"StockholdersEquity_0_Q3_USD":95057000.0,"ShortTermLeaseCost_3_Q3_USD":20000.0,"ShortTermLeaseCost_1_Q3_USD":7000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3_Q3_pure":0.005,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q3_pure":0.008,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3_Q3_pure":0.012,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q3_pure":0.012,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3_Q3_pure":0.82,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q3_pure":0.82,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_3_Q3_pure":0.85,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q3_pure":0.83,"ShareBasedCompensation_3_Q3_USD":9439000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":730000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-915781000.0,"RestrictedCashAndCashEquivalents_0_Q3_USD":300000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":49720000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":21618000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":88000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":429000.0,"ProfitLoss_3_Q3_USD":-69192000.0,"ProceedsFromWarrantExercises_3_Q3_USD":810000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":677000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":55364000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":5647000.0,"NetIncomeLoss_1_Q3_USD":-28647000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-63714000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-40000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":213000.0,"Depreciation_3_Q3_USD":32000.0,"Depreciation_1_Q3_USD":11000.0,"CommonStockValue_0_Q3_USD":14000.0,"CommonStockSharesOutstanding_0_Q3_shares":14498953.0,"CommonStockSharesIssued_0_Q3_shares":14498953.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":17218269.0,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-6987000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":97368000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":97068000.0,"Cash_0_Q3_USD":2479000.0,"AssetsCurrent_0_Q3_USD":102715000.0,"Assets_0_Q3_USD":104227000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":15923000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":9439000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":3280000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":3280000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1010824000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":341000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1252000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":7781000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":3804000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-2.1,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-5.5,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-84000.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":56851000.0,"MoneyMarketFundsAtCarryingValue_0_Q3_USD":94589000.0,"LiabilitiesCurrent_0_Q3_USD":8627000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":104227000.0,"Liabilities_0_Q3_USD":9170000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":66000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":109000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":223000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":230000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":58000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":397000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":1017000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":13672633.0,"LeaseCost_3_Q3_USD":229000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":3263000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":369000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-1358000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":124000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":47000.0,"IncomeTaxesPaidNet_3_Q3_USD":51000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-69068000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-28600000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":19274000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":6985000.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_3_Q3_USD":0.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_1_Q3_USD":0.0,"LeaseCost_1_Q3_USD":98000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":12571096.0,"Ticker":"SRRA","CIK":"1290149","name":"SIERRA ONCOLOGY, INC.","OfficialName":"Sierra Oncology Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1244659116.0","Country":"Canada","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211105"}]